Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) Sees Significant Growth in Short Interest

Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) was the recipient of a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 152,000 shares, a growth of 29.6% from the November 15th total of 117,300 shares. Based on an average daily trading volume, of 148,600 shares, the short-interest ratio is presently 1.0 days. Approximately 0.9% of the shares of the company are short sold.

Inspira Technologies Oxy B.H.N. Trading Down 2.1 %

Shares of NASDAQ IINN traded down $0.03 during midday trading on Friday, reaching $1.17. The company’s stock had a trading volume of 107,172 shares, compared to its average volume of 417,584. Inspira Technologies Oxy B.H.N. has a 12-month low of $0.76 and a 12-month high of $2.49. The firm has a 50 day moving average price of $1.32 and a 200-day moving average price of $1.33. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.23 and a quick ratio of 2.13.

Hedge Funds Weigh In On Inspira Technologies Oxy B.H.N.

An institutional investor recently bought a new position in Inspira Technologies Oxy B.H.N. stock. Renaissance Technologies LLC bought a new position in Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 24,497 shares of the company’s stock, valued at approximately $34,000. Renaissance Technologies LLC owned about 0.19% of Inspira Technologies Oxy B.H.N. as of its most recent SEC filing. 12.72% of the stock is currently owned by institutional investors.

Inspira Technologies Oxy B.H.N. Company Profile

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.